The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Graph of HIV levels (red) and decline in T cells (blue) during progression of HIV/AIDS
Graph of HIV levels (red) and decline in T cells (blue) during progression of HIV/AIDS

AIDS is a progressive immunodeficiency disease first recognised in 1981, caused by infection with human immunodeficiency virus (HIV). Initial infection is sometimes associated with a brief influenza-like illness, followed by a period of 3–20 years without symptoms during which the immune system deteriorates. The individual becomes highly susceptible to common infections such as tuberculosis, as well as opportunistic infections, such as Pneumocystis pneumonia, and tumours, such as Kaposi's sarcoma and lymphoma. Severe weight loss is also a feature of AIDS. Without treatment, the average survival time after infection is around 9–11 years, depending on the HIV subtype.

HIV/AIDS is a global pandemic. As of 2018, nearly 38 million people worldwide are estimated to be infected with HIV, with 1.8 million new infections occurring each year. AIDS has caused around 32 million deaths. The major routes of transmission are unsafe heterosexual or male/male sex, contaminated needles and blood transfusions, and from mother to child, either at birth or via breastfeeding. Combination antiretroviral therapy does not eliminate the virus, but delays progression to AIDS and can lead to a near-normal life expectancy. Drugs to prevent infection are now available, but there is no effective HIV vaccine.

Selected image

Scanning electron micrograph of HIV budding from lymphocytes

HIV-1 budding from lymphocytes in culture. HIV establishes a latent infection in several types of immune cell and causes profound immunodeficiency.

Credit: C. Goldsmith (1984)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Ribbon diagram of the Dicer enzyme from Giardia intestinalis
Ribbon diagram of the Dicer enzyme from Giardia intestinalis

RNA interference is a type of gene silencing that forms an important part of the immune response against viruses and other foreign genetic material in plants and many other eukaryotes. A cell enzyme called Dicer (pictured) cleaves double-stranded RNA molecules found in the cell cytoplasm – such as the genome of an RNA virus or its replication intermediates – into short fragments termed small interfering RNAs (siRNAs). These are separated into single strands and integrated into a large multi-protein RNA-induced silencing complex, where they recognise their complementary messenger RNA (mRNA) molecules and target them for destruction. This prevents the mRNAs acting as a template for translation into proteins, and so inhibits, or silences, the expression of viral genes.

RNA interference allows the entire plant to respond to a virus after a localised encounter, as the siRNAs can transfer between cells via plasmodesmata. The protective effect can be transferred between plants by grafting. Many plant viruses have evolved elaborate mechanisms to suppress this response. RNA interference evolved early in eukaryotes, and the system is widespread. It is important in innate immunity towards viruses in some insects, but relatively little is known about its role in mammals. Research is ongoing into the application of RNA interference to antiviral treatments.

Selected outbreak

American soldiers with influenza H1N1 at a hospital ward at Camp Funston
American soldiers with influenza H1N1 at a hospital ward at Camp Funston

The 1918–20 influenza pandemic, the first of the two involving H1N1 influenza virus, was unusually deadly. It infected 500 million people across the entire globe, with a death toll of 50–100 million (3–5% of the world's population), making it one of the deadliest natural disasters of human history. It has also been implicated in the outbreak of encephalitis lethargica in the 1920s. Despite the nickname "Spanish flu", the pandemic's geographic origin is unknown.

Most influenza outbreaks disproportionately kill young, elderly or already weakened patients; in contrast this predominantly killed healthy young adults. Contemporary medical reports suggest that malnourishment, overcrowded medical facilities and poor hygiene promoted fatal bacterial pneumonia. Some research suggests that the virus might have killed through a cytokine storm, an overreaction of the body's immune system. This would mean the strong immune reactions of young adults resulted in a more severe disease than the weaker immune systems of children and older adults.

Selected quotation

Donald McNeil on the campaign to eradicate polio

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

X-ray crystallographic structure of the Norwalk virus capsid
X-ray crystallographic structure of the Norwalk virus capsid

Noroviruses are a genus of non-enveloped, single-stranded RNA viruses in the family Caliciviridae. The positive-sense RNA genome is approximately 7500 nucleotides long. Known noroviruses fall into five different genogroups (GI–GV); three groups infect humans, the other two mice, and cattle and other bovines. All are considered strains of a single species, Norwalk virus.

Noroviruses are extremely contagious, with fewer than 20 virus particles being infectious. They are transmitted directly from person to person and indirectly via contaminated water and food. After infection, the virus replicates in the small intestine, causing acute gastroenteritis, which develops 12–48 hours after exposure and lasts for 24–72 hours. The characteristic symptoms include nausea, forceful vomiting, watery diarrhoea and abdominal pain. Infection is usually self-limiting and rarely severe. Noroviruses cause 18% of acute gastroenteritis episodes in humans, with around 685 million cases and 200,000 deaths every year, mainly in very young, elderly or immunosuppressed people. No vaccine is available. Hand washing with soap and water is effective in reducing transmission.

Did you know?

HMAT Boonah
HMAT Boonah

Selected biography

Thomas Flewett in 1984

Thomas Flewett (29 June 1922 – 12 December 2006) was a British–Irish virologist and an authority on electron microscopy of viruses, best known for his role in the discovery of rotaviruses. After Ruth Bishop and others discovered viruses associated with diarrhoea, Flewett showed that they could be visualised by electron microscopy directly in faeces. He dubbed them "rotaviruses" for their wheel-shaped appearance. His group described the different rotavirus serotypes, and did extensive research on the rotavirus varieties infecting many animals.

Flewett established one of the first English virus laboratories in Birmingham in 1956. In addition to his rotavirus work, he discovered the cause of hand, foot and mouth disease, identified two new species of adenovirus, and co-discovered human torovirus and picobirnaviruses. His other research included influenza, coxsackie A, coxsackie B and hepatitis B viruses.

In this month

Louis Pasteur in 1878

1 July 1796: Edward Jenner first challenged James Phipps with variolation, showing that cowpox inoculation is protective against smallpox

3 July 1980: Structure of southern bean mosaic virus solved by Michael Rossmann and colleagues

6 July 1885: Louis Pasteur (pictured) gave rabies vaccine to Joseph Meister

10 July 1797: Jenner submitted paper on Phipps and other cases to the Royal Society; it was read to the society but not published

14–20 July 1968: First International Congress for Virology held in Helsinki

16 July 2012: FDA approved tenofovir/emtricitabine (Truvada) for prophylactic use against HIV; first prophylactic antiretroviral

19 July 2013: Pandoravirus described, with a genome twice as large as Megavirus

22 July 1966: International Committee on Nomenclature of Viruses (later the ICTV) founded

25 July 1985: Film star Rock Hudson made his AIDS diagnosis public, increasing public awareness of the disease

28 July 2010: First global World Hepatitis Day

Selected intervention

Ball-and-stick model of zidovudine
Ball-and-stick model of zidovudine

Zidovudine (ZDV) (also known as AZT and sold as Retrovir) is an antiretroviral drug used in the prevention and treatment of HIV/AIDS. Classed as a nucleoside analogue reverse-transcriptase inhibitor, it inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. The first breakthrough in AIDS therapy, ZDV was licensed in 1987. While it significantly reduces HIV replication, leading to some clinical and immunological benefits, when used alone ZDV does not completely stop replication, allowing the virus to become resistant to it. The drug is therefore used together with other anti-HIV drugs in combination therapy called highly active antiretroviral therapy. To simplify its administration, ZDV is included in combination pills with lamivudine (Combivir) and lamivudine plus abacavir (Trizivir). ZDV continues to be used to prevent HIV transmission from mother to child during childbirth; it was previously part of the standard post-exposure prophylaxis after needlestick injury.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: